Craig Hopkinson will become Alkermes plc's chief medical officer on Feb. 1, 2018.
He will be joined by Mark Namchuk, who will serve as senior vice president of research, pharmaceutical and non-clinical development, to assume all leadership responsibilities for the company's research and development organization.
